Clinical Trial Update: The Use of a Water Soluble Under the Tongue (Sublingual) CBD Tablet for Treating Pain Associated With Diabetic Peripheral Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating a water-soluble sublingual CBD tablet for pain associated with diabetic neuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy
• Diabetic Peripheral Neuropathy

Drugs mentioned

• Water Soluble Sublingual CBD Tablet (cannabinoid cannabidiol (CBD))

Snippet

Sponsor: Pure Green | Conditions: Diabetic Neuropathies | Phase 2 | Status: COMPLETED